Julie Johnson is a leader in the field of personalized medicine, particularly for cardiovascular treatment. She joined the faculty at the University of Florida in 1998 following nine years on the University of Tennessee College of Pharmacy faculty and was named dean of the UF College of Pharmacy in July 2013. Her research into how genes influence individual patients' responses to important cardiovascular drugs, including blood thinners and medications regulating blood pressure, has already found use in the field. In June 2012 UF Health began using a blood test to determine whether cardiac catheterization patients should be administered clopidogrel, a commonly prescribed anti-clotting drug, and found that approximately 28 percent have a genetic variation indicating a different medication should be used. The healthcare system is now storing this information in patient medical records and expanding the research to other medications.

Twitter: @UFPersonalMed